TMCnet News
Research and Markets: Global Liver Fibrosis Clinical Trials Report - H2 2013 ReviewDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/gf83km/liver_fibrosis) has announced the addition of the "Liver Fibrosis Global Clinical Trials Review, H2, 2013" report to their offering. Liver Fibrosis Global Clinical Trials Review, H2, 2013" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the ke drugs for treating Liver Fibrosis. Scope
Top Companies Participating in Liver Fibrosis Therapeutics Clinical Trials
Clinical Trial Overview of Top Institutes / Government
For more information visit http://www.researchandmarkets.com/research/gf83km/liver_fibrosis
|